Literature DB >> 1501682

Some relationships between addiction and drug delivery to the brain.

W H Oldendorf1.   

Abstract

Hemodynamic radioisotope studies of brain blood flow in humans have been correlated with the delivery of some common addictive drugs. Both lipophilic and hydrophilic tracers were used in the hemodynamic studies. Iodoantipyrine is lipophilic and is completely cleared by brain during a single brain circulatory passage, as are cocaine and nicotine. Iodohippurate is hydrophilic, so its brain clearance after IV injection resembles that of morphine. The earlier studies performed in humans have been related here with recent studies of blood brain penetration of drugs of abuse. As presented, these separate studies are consistent with the proposed hypothesis that the interval between drug intake and perceived effect is a significant consideration when explaining severity of addiction. The shorter the time interval between drug intake and its perceived effect, the more severe the addiction appears to be. This relationship may explain differences in severity of addiction to the same drug taken by various routes of administration.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1501682

Source DB:  PubMed          Journal:  NIDA Res Monogr        ISSN: 1046-9516


  20 in total

Review 1.  Neuroimaging in drug abuse.

Authors:  Kimberly P Lindsey; S John Gatley; Nora D Volkow
Journal:  Curr Psychiatry Rep       Date:  2003-10       Impact factor: 5.285

2.  Assessment of a formulation designed to be crush-resistant in prescription opioid abusers.

Authors:  Suzanne K Vosburg; Jermaine D Jones; Jeanne M Manubay; Judy B Ashworth; Irma H Benedek; Sandra D Comer
Journal:  Drug Alcohol Depend       Date:  2012-06-20       Impact factor: 4.492

3.  Temporal relationships between the pharmacokinetics of methylphenidate in the human brain and its behavioral and cardiovascular effects.

Authors:  N D Volkow; G J Wang; S J Gatley; J S Fowler; Y S Ding; J Logan; R Hitzemann; B Angrist; J Lieberman
Journal:  Psychopharmacology (Berl)       Date:  1996-01       Impact factor: 4.530

4.  CTDP-32476: A Promising Agonist Therapy for Treatment of Cocaine Addiction.

Authors:  Zheng-Xiong Xi; Rui Song; Xia Li; Guan-Yi Lu; Xiao-Qing Peng; Yi He; Guo-Hua Bi; Siyuan Peter Sheng; Hong-Ju Yang; Haiying Zhang; Jin Li; Mark Froimowitz; Eliot L Gardner
Journal:  Neuropsychopharmacology       Date:  2016-08-18       Impact factor: 7.853

Review 5.  [Why do schizophrenic patients smoke?].

Authors:  K Cattapan-Ludewig; S Ludewig; E Jaquenoud Sirot; M Etzensberger; F Hasler
Journal:  Nervenarzt       Date:  2005-03       Impact factor: 1.214

6.  The rate of intravenous cocaine or amphetamine delivery does not influence drug-taking and drug-seeking behavior in rats.

Authors:  Hans S Crombag; Carrie R Ferrario; Terry E Robinson
Journal:  Pharmacol Biochem Behav       Date:  2008-10       Impact factor: 3.533

Review 7.  Nicotine-related brain disorders: the neurobiological basis of nicotine dependence.

Authors:  E L Ochoa
Journal:  Cell Mol Neurobiol       Date:  1994-06       Impact factor: 5.046

8.  Oral administration of methylphenidate blocks the effect of cocaine on uptake at the Drosophila dopamine transporter.

Authors:  E Carina Berglund; Monique A Makos; Jacqueline D Keighron; Nhu Phan; Michael L Heien; Andrew G Ewing
Journal:  ACS Chem Neurosci       Date:  2013-02-25       Impact factor: 4.418

9.  Methylphenidate Abuse and Psychiatric Side Effects.

Authors:  W Alexander Morton; Gwendolyn G. Stockton
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2000-10

10.  Can abuse deterrent formulations make a difference? Expectation and speculation.

Authors:  Simon H Budman; Jill M Grimes Serrano; Stephen F Butler
Journal:  Harm Reduct J       Date:  2009-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.